Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer

NCT01219075 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

110

Enrollment

OTHER

Sponsor class

Conditions

BRCA1 Mutation Carrier
BRCA2 Mutation Carrier
Ductal Breast Carcinoma in Situ
Lobular Breast Carcinoma in Situ
Stage IA Breast Cancer
Stage IB Breast Cancer
Stage II Breast Cancer
Stage IIIA Breast Cancer
Stage IIIB Breast Cancer

Interventions

DIETARY_SUPPLEMENT: soy isoflavones
OTHER: placebo
OTHER: questionnaire administration
PROCEDURE: magnetic resonance imaging
PROCEDURE: biopsy
OTHER: immunohistochemistry staining method
OTHER: laboratory biomarker analysis
PROCEDURE: mammography

Sponsor

University of Southern California

Collaborators

[object Object]
[object Object]